This article was originally published in The Tan Sheet
"OTC feedback" meeting set for April 14 with NDMA to discuss the association's petition asking the agency to clarify to EPA and state agencies that regulatory enforcement responsibility for OTC pediculicides has been transferred to FDA under December 1993 pediculicide final monograph ("The Tan Sheet" March 14, In Brief)
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC